FacebookTwitterRedditEmail

Pharma Funded “Patient” Groups Keep Drug Prices Astronomical

adult adhd

It happens with regularity during citizen open-mike sessions at FDA drug advisory committee hearings. A queue of “patients” materializes out of nowhere to testify, often in tears, about the crucial need for a new drug or new use approval. Some are flown in by Pharma.

It can’t be a generic drug, cry the “patients” because, they are just not the same. It has to be the $1000 a month drug or even the $1000 a pill drug  so that taxpayers and the privately insured prop up Pharma’s cred on Wall Street.

While more than 80 percent of patient groups are Pharma funded the New York Times reported this week including the National Hemophilia Foundation, the American Diabetes Association and the National Psoriasis Foundation, mental health front groups which include the National Alliance for Mental Health (NAMI) and Mental Health America are the most insidious.

Not only do psychiatric drugs represent four digit outlays per month per patient  and sometimes much more, patients are kept on them for decades or life—with few medical attempts to determine if patients still need them or ever needed them.  Side effects of the drug cocktails are viewed, thanks to Pharma spin, as confirmation of the “mental illness” not the side effects they almost always are. The use of such drugs in the elderly, despite their links to death in those with dementia, has become epidemic and is an underreported cause of falls.

“Mental illness” is a category deliberately “grown” by Pharma with aggressive and unethical million dollar campaigns. These campaigns, often unbranded to look like a public service, convince people with real life challenges they are “depressed” or “bipolar” and that their children have ADHD. Despite the Pharma marketing, the New England Journal of Medicine recently reported that the rate of severe mental illness among children and adolescents has actually dropped dramatically in the past generation.

The tactics of these front groups have been widely reported. “When insurers balk at reimbursing patients for new prescription medications, these groups typically swing into action, rallying sufferers to appear before public and consumer panels, contact lawmakers, and provide media outlets a human face to attach to a cause,” reported the Los Angeles Times .

Targeting poor people on government health plans is Pharma’s marketing plan. “For years, the alliance [NAMI] has fought states’ legislative efforts to limit doctors’ freedom to prescribe drugs, no matter how expensive, to treat mental illness in patients who rely on government health care programs like Medicaid, says the New York Times . “Some of these medicines routinely top the list of the most expensive drugs that states buy for their poorest patients.”

Thanks to the Sunshine Act, part of the Affordable Care Act, it is possible to see what Pharma is paying patient front groups and the numbers are astounding. Last year Eli Lilly, one of the primary makers of psychiatric drugs, bestowed an astonishing 22 grants on NAMI including $25,000 for its “Healthy Americas Briefings.” How objective are those “briefings”? Pfizer gave NAMI $32,500 during one quarter last year.

Lilly also greased the palms of Mental Health America to the tune of $35,000 last year. Government is increasingly funding Mental Health America, adding to the Pharma exploitation and heisting of our tax dollars. Last year, Counterpunch reported that Walgreens had announced a partnership with Mental Health America. The plan empowered Walgreens to “screen” customers to see if they might need expensive psychiatric drugs but not know it–until Pharma magnanimously told them.  Screening is widely viewed, even by the medical establishment, as shameless Pharma marketing that leads to over-diagnosis, over-treatment and over-medication even as people who actually need medical treatment are ignored.

The Pharma business model actually wants people sick. Currently, in radio campaigns, Pharma is trying to convince people they have “exocrine pancreatic insufficiency” and “Non-24 Sleep Wake Disorder” two conditions so rare as to be laughable as radio campaigns.

How much do the drugs Pharma, NAMI, Mental Health America and Walgreens push cost?  If a “bipolar” child is prescribed a middle dose of the mood stabilizers Topamax and Lamictal, the yearly cost would be $23,220. If Seroquel is added, at a cost of $24,000, along with the ADHD drug Concerta at $7,812, and Neurontin at $4,860, one bipolar child would make Pharma $59,892 a year. Remember, you can’t substitute a generic.

More articles by:

Martha Rosenberg is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

bernie-the-sandernistas-cover-344x550
April 01, 2020
Marshall Sahlins
Trumpty’s Country
Steve Early - Suzanne Gordon
No Pandemic-Related Pause? VA Privatization Leaves Veterans Waist Deep in Another Big Muddy 
Kenneth Surin
The UK and Covid-19 Crisis
Jack Wareham - Dylan Burgoon
“Whose University? Our University!” The Struggle for a COLA at UC Berkeley
Erik Molvar
Oil industry Exploits Pandemic as Excuse to Dodge Federal Regulations, Fees
Robert Jensen
Apocalypse, Now and Forever
Jake Johnston – Kira Paulemon
COVID-19 in Haiti: the Current Response and Challenges
Jen Moore
Guatemalan Water Protectors Persist, Despite Mining Company Threats
Danny Shaw
“The Coronavirus is Man-Made:” the Conspiracy Theory Trap 
Nafeez Ahmed
Former WHO Director: 8-Week Suppression Strategy Could Stop US COVID Crisis in Its Tracks
Frances Madeson
Death Camps in the Making: New York’s Prisons During a Time of Pandemic
Clark T. Scott
The White House and the CDC are United in Stupidity
George Ochenski
What Does COVID-19 Have to Do With Industrial Pollution?
Norman Solomon
Trump’s Mass Negligent Homicide Doesn’t Let Democratic Leaders Off the Hook
Scott Owen
Another New Peace
Elizabeth Schmidt
Lessons From Africa: Military Intervention Fails to Counter Terrorism
Greta Anderson
What’s the Hang Up on Releasing Adult Lobos?
Ted Rall
The Speech Trump Must But Cannot Give
March 31, 2020
Jonathan Cook
Netanyahu Uses Coronavirus to Lure Rival Gantz into ‘Emergency’ Government
Vijay Prashad, Du Xiaojun – Weiyan Zhu
Growing Xenophobia Against China in the Midst of CoronaShock
Patrick Cockburn
Trump’s Chernobyl Moment: the US May Lose Its Status as World Superpower and Not Recover
Roger Harris
Beyond Chutzpah: US Charges Venezuela With Nacro-Terrorism
M. K. Bhadrakumar
Has America Reached Its Endgame in Afghanistan?
Thomas Klikauer
COVID-19 in Germany: Explaining a Low Death Rate
Dave Lindorff
We’ve Met the Enemy and It’s a Tiny Virus
Binoy Kampmark
Barbaric Decisions: Coronavirus, Refusing Bail and Julian Assange
Nicolas J S Davies
Why is the U.S. so Exceptionally Vulnerable to Covid-19?
James Bovard
The Deep State’s Demolition of Democracy
Michael Doliner
Face Off: the Problem With Social Distancing
John Feffer
The Politics of COVID-19
Mel Gurtov
Trump’s Cure and Our Disease
Howard Lisnoff
The Fault Lines of a Failed Society Begin to Open Up Into Chasms
Nino Pagliccia
Cuba: An Example of Solidarity In a Time of Crisis
Ralph Nader
Out of the Coronavirus Crisis Can Come Efficient Historic Changes for Justice
Thomas Stephens
Apocalyptic and Revolutionary Education in Times of Pandemic
Edward Martin
Erik Olin Wright and the Anti-Capitalist Economy
March 30, 2020
Marshall Auerback
Washington Uses the Pandemic to Create a $2 Trillion Slush Fund for Its Cronies
Ron Jacobs
Going After Maduro
Justin Podur
When Economists Try to Solve Health Crises, the Results Can Often be Disastrous
Thomas Knapp
Decarceration: COVID-19 is Opportunity Knocking
Arshad Khan - Meena Miriam Yust
Dying Planet and a Virus Unleashed
William Astore
How My Dad Predicted the Decline of America
Seth Sandronsky
Reclaiming Vacant Homes in the COVID-19 Pandemic
John G. Russell
Racial Profiling Disorder: the All-American Pandemic
Vijay Prashad, Paola Estrada, Ana Maldonado, and Zoe PC
As the World Tackles the COVID-19 Pandemic, the U.S. Raises the Pressure on Venezuela
FacebookTwitterRedditEmail